Mark Galeotti LIVE Interview
Dr. Mark Galeotti has been researching Russian security issues since the late 1980s. Educated at Cambridge University and the LSE, he is now Clinical Professor of Global Affairs and Academic Chair of New York University's Center for Global Affairs. Until 2008, he was head of the History department at Keele University in the UK as well as director of its Organized Russian & Eurasian Crime Research Unit. His books include the edited collections 'The Politics of Security in Modern Russia' (Ashgate), 'Russian & Soviet Organized Crime' (Ashgate) and 'Global Crime Today' (Routledge) and he is a regular contributor to Jane's Intelligence Review, Oxford Analytica and many other outlets.
The best-selling author tells us his methods.
- James Patterson has sold 300 million copies of his 130 books, making him one of the most successful authors alive today.
- He talks about how some writers can overdo it by adding too much research, or worse, straying from their outline for too long.
- James' latest book, The President is Missing, co-written with former President Bill Clinton, is out now.
Pfizer's partnerships strengthen their ability to deliver vaccines in developing countries.
- Community healthcare workers face many challenges in their work, including often traveling far distances to see their clients
- Pfizer is helping to drive the UN's sustainable development goals through partnerships.
- Pfizer partnered with AMP and the World Health Organization to develop a training program for healthcare workers.
It's the first time the association hasn't hired a comedian in 16 years.
- The 2018 WHCA ended in controversy after comedian Michelle Wolf made jokes some considered to be offensive.
- The WHCA apologized for Wolf's jokes, though some journalists and many comedians backed the comedian and decried arguments in favor of limiting the types of speech permitted at the event.
- Ron Chernow, who penned a bestselling biography of Alexander Hamilton, will speak at next year's dinner.
SMARTER FASTER trademarks owned by The Big Think, Inc. All rights reserved.